Intensive care management of acute stroke: general management
J. Diedler,
M. Sykora,
E. Jüttler,
T. Steiner,
W. Hacke,
Corresponding Author
J. Diedler
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Jennifer Diedler*, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. Tel: +49 6221 56 37557; Fax: +49 6221 56 5258; e-mail: [email protected]Search for more papers by this authorM. Sykora
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Department of Neurology, Comenius University, Bratislava, Slovakia
Search for more papers by this authorE. Jüttler
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Center for Stroke Research Berlin (CSB), Charité University Medicine Berlin, Campus Mitte, Berlin, Germany
Search for more papers by this authorT. Steiner
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Search for more papers by this authorW. Hacke
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Search for more papers by this authorJ. Diedler,
M. Sykora,
E. Jüttler,
T. Steiner,
W. Hacke,
Corresponding Author
J. Diedler
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Jennifer Diedler*, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. Tel: +49 6221 56 37557; Fax: +49 6221 56 5258; e-mail: [email protected]Search for more papers by this authorM. Sykora
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Department of Neurology, Comenius University, Bratislava, Slovakia
Search for more papers by this authorE. Jüttler
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Center for Stroke Research Berlin (CSB), Charité University Medicine Berlin, Campus Mitte, Berlin, Germany
Search for more papers by this authorT. Steiner
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Search for more papers by this authorW. Hacke
Department of Neurology, University of Heidelberg, Heidelberg, Germany
Search for more papers by this authorFirst published: 16 September 2009
Abstract
For a long time, patients with severe stroke were facing therapeutic nihilism of the attending physicians. Implementation of do-not-resuscitate-orders may have lead to self-fulfilling prophecies and to a pessimistic overestimation of prognosis of severe stroke syndromes. However, there have been great advances in intensive care management of acute stroke patients and it has been shown that treatment on a specialised neurological intensive care unit improves outcome. In this review, we will present a summary of the current state-of-the-art intensive care management of acute stroke patients. After presenting an overview on general management of stroke intensive care patients, special aspects of neurological intensive care of acute large middle cerebral artery stroke, intracerebral haemorrhage and subarachnoid haemorrhage will be discussed. In part II of the review, surgical management options for acute stroke will be discussed in detail.
References
- 1 Mayer SA, Copeland D, Bernardini GL et al. Cost and outcome of mechanical ventilation for life-threatening stroke. Stroke 2000; 31: 2346–53.
- 2 Muench E, Bauhuf C, Roth H et al. Effects of positive end-expiratory pressure on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation. Crit Care Med 2005; 33: 2367–72.
- 3 Georgiadis D, Schwarz S, Baumgartner RW et al. Influence of positive end-expiratory pressure on intracranial pressure and cerebral perfusion pressure in patients with acute stroke. Stroke 2001; 32: 2088–92.
- 4 Georgiadis D, Schwarz S, Kollmar R et al. Influence of inspiration: expiration ratio on intracranial and cerebral perfusion pressure in acute stroke patients. Intensive Care Med 2002; 28: 1089–93.
- 5 Scales DC, Thiruchelvam D, Kiss A et al. The effect of tracheostomy timing during critical illness on long-term survival. Crit Care Med 2008; 36: 2688–9.
- 6 Dunham CM, Ransom KJ. Assessment of early tracheostomy in trauma patients: a systematic review and meta-analysis. Am Surg 2006; 72: 276–81.
- 7 Qureshi AI, Suarez JI, Parekh PD et al. Prediction and timing of tracheostomy in patients with infratentorial lesions requiring mechanical ventilatory support. Crit Care Med 2000; 28: 1383–7.
- 8 Huttner HB, Kohrmann M, Berger C et al. Predictive factors for tracheostomy in neurocritical care patients with spontaneous supratentorial hemorrhage. Cerebrovasc Dis 2006; 21: 159–65.
- 9 Kelly DF, Goodale DB, Williams J et al. Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial. J Neurosurg 1999; 90: 1042–52.
- 10 Chamorro C, De Latorre FJ, Montero A et al. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial. Crit Care Med 1996; 24: 932–9.
- 11 Prasad A, Worrall BB, Bertram EH et al. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001; 42: 380–6.
- 12 Bourgoin A, Albanese J, Wereszczynski N et al. Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil. Crit Care Med 2003; 31: 711–7.
- 13 Tipps LB, Coplin WM, Murry KR et al. Safety and feasibility of continuous infusion of remifentanil in the neurosurgical intensive care unit. Neurosurgery 2000; 46: 596–601; discussion 601–2.
- 14 Hanel F, Werner C, Von Knobelsdorff G et al. The effects of fentanyl and sufentanil on cerebral hemodynamics. J Neurosurg Anesthesiol 1997; 9: 223–7.
- 15 Schwab S, Aschoff A, Spranger M et al. The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology 1996; 47: 393–8.
- 16 Steiner T, Pilz J, Schellinger P et al. Multimodal online monitoring in middle cerebral artery territory stroke. Stroke 2001; 32: 2500–6.
- 17 Dohmen C, Bosche B, Graf R et al. Identification and clinical impact of impaired cerebrovascular autoregulation in patients with malignant middle cerebral artery infarction. Stroke 2007; 38: 56–61.
- 18 Dohmen C, Bosche B, Graf R et al. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke 2003; 34: 2152–8.
- 19 Berger C, Kiening K, Schwab S. Neurochemical monitoring of therapeutic effects in large human MCA infarction. Neurocrit Care 2008; 9: 352–6.
- 20 Diedler J, Sykora M, Rupp A et al. Impaired cerebral vasomotor activity in spontaneous intracerebral hemorrhage. Stroke 2009; 40: 815–9.
- 21 Rose JC, Neill TA, Hemphill JC III Continuous monitoring of the microcirculation in neurocritical care: an update on brain tissue oxygenation. Curr Opin Crit Care 2006; 12: 97–102.
- 22 Sarrafzadeh AS, Sakowitz OW, Kiening KL et al. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients? Crit Care Med 2002; 30: 1062–70.
- 23 Vajkoczy P, Horn P, Thome C et al. Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003; 98: 1227–34.
- 24 Claassen J, Mayer SA. Continuous electroencephalographic monitoring in neurocritical care. Curr Neurol Neurosci Rep 2002; 2: 534–40.
- 25 Claassen J, Hirsch LJ, Kreiter KT et al. Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol 2004; 115: 2699–710.
- 26 Steiner LA, Czosnyka M, Piechnik SK et al. Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury. Crit Care Med 2002; 30: 733–8.
- 27 Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992; 77: 584–9.
- 28 Bereczki D, Liu M, Do Prado GF et al. Mannitol for acute stroke. Stroke 2008; 39: 512–13.
- 29 Schwarz S, Schwab S, Bertram M et al. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998; 29: 1550–5.
- 30 Biestro A, Alberti R, Galli R et al. Osmotherapy for increased intracranial pressure: comparison between mannitol and glycerol. Acta Neurochir (Wien) 1997; 139: 725–32; discussion 732–3.
- 31 Gemma M, Cozzi S, Tommasino C et al. 7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol 1997; 9: 329–34.
- 32 Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000; 28: 3301–13.
- 33 Schwarz S, Georgiadis D, Aschoff A et al. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002; 33: 136–40.
- 34 Ogden AT, Mayer SA, Connolly ES Jr Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery 2005; 57: 207–15; discussion 207–15.
- 35 Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore) 1990; 69: 153–9.
- 36 Wolf AL, Levi L, Marmarou A et al. Effect of THAM upon outcome in severe head injury: a randomized prospective clinical trial. J Neurosurg 1993; 78: 54–9.
- 37 Schwartz ML, Tator CH, Rowed DW et al. The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci 1984; 11: 434–40.
- 38 Schwab S, Spranger M, Schwarz S et al. Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology 1997; 48: 1608–13.
- 39 Christensen MS, Paulson OB, Olesen J et al. Cerebral apoplexy (stroke) treated with or without prolonged artificial hyperventilation. 1. Cerebral circulation, clinical course, and cause of death. Stroke 1973; 4: 568–631.
- 40 Muizelaar JP, Marmarou A, Ward JD et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg 1991; 75: 731–9.
- 41 Marion DW, Puccio A, Wisniewski SR et al. Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med 2002; 30: 2619–25.
- 42 Bardutzky J, Schwab S. Antiedema therapy in ischemic stroke. Stroke 2007; 38: 3084–94.
- 43 Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev, 2001. CD000039.
- 44 Adams HP Jr, Del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke. Circulation 2007; 115: e478–534.
- 45 Ringleb PA, Bousser MG, Ford G et al. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457–507.
- 46 Potter J, Robinson T, Ford G et al. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: rationale and design. J Hypertens 2005; 23: 649–55.
- 47 Kidwell CS, Saver JL, Mattiello J et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology 2001; 57: 1611–7.
- 48 Herweh C, Juttler E, Schellinger PD et al. Evidence against a perihemorrhagic penumbra provided by perfusion computed tomography. Stroke 2007; 38: 2941–7.
- 49 Powers WJ, Zazulia AR, Videen TO et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 2001; 57: 18–24.
- 50 Anderson CS, Huang Y, Wang JG et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008; 7: 391–9.
- 51 Davis SM, Broderick J, Hennerici M et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66: 1175–81.
- 52 Mayer SA, Brun NC, Begtrup K et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358: 2127–37.
- 53 Broderick J, Connolly S, Feldmann E et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007; 116: e391–413.
- 54 Steiner T, Kaste M, Forsting M et al. Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006; 22: 294–316.
- 55 Capes SE, Hunt D, Malmberg K et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426–32.
- 56 Van Den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359–67.
- 57 Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449–61.
- 58 Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125–39.
- 59 Gray CS, Hildreth AJ, Sandercock PA et al. Glucose–potassium–insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007; 6: 397–406.
- 60 Dellinger RP, Levy MM, Carlet JM et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296–327.
- 61 Takagi K. Body temperature in acute stroke. Stroke 2002; 33: 2154–5; author reply 2154–5.
- 62 Schwarz S, Hafner K, Aschoff A et al. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000; 54: 354–61.
- 63 Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 1998; 29: 529–34.
- 64 Langhorne P, Stott DJ, Robertson L et al. Medical complications after stroke: a multicenter study. Stroke 2000; 31: 1223–9.
- 65 Kamphuisen PW, Agnelli G, Sebastianelli M. Prevention of venous thromboembolism after acute ischemic stroke. J Thromb Haemost 2005; 3: 1187–94.
- 66 Kelly J, Rudd A, Lewis RR et al. Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke 2004; 35: 2320–5.
- 67 Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc 1997; 72: 297–300.
- 68 Mazzone C, Chiodo GF, Sandercock P et al. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev 2004; CD001922.
- 69 Diener HC, Ringelstein EB, Von Kummer R et al. Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial. Stroke 2006; 37: 139–44.
- 70 Sherman DG, Albers GW, Bladin C et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet 2007; 369: 1347–55.
- 71 Boeer A, Voth E, Henze T et al. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1991; 54: 466–7.
- 72 Dorffler-Melly J, De Jonge E, Pont AC et al. Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet 2002; 359: 849–50.
- 73 Franchini M. The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol 2007; 82: 731–5.
- 74 Blanco M, Nombela F, Castellanos M et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 2007; 69: 904–10.
- 75 Amarenco P, Bogousslavsky J, Callahan A III et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–59.
- 76 FitzMaurice E, Wendell L, Snider R et al. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 2008; 39: 2151–4.
- 77 Baigent C, Keech A, Kearney PM et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–78.
- 78 Hofmeijer J, Van Der Worp HB, Kappelle LJ. Treatment of space-occupying cerebral infarction. Crit Care Med 2003; 31: 617–25.
- 79 Hacke W, Schwab S, Horn M et al. Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53: 309–15.
- 80 Vahedi K, Hofmeijer J, Juettler E et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6: 215–22.
- 81 Schwab S, Schwarz S, Spranger M et al. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998; 29: 2461–6.
- 82 Schwab S, Georgiadis D, Berrouschot J et al. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 2001; 32: 2033–5.
- 83 Georgiadis D, Schwarz S, Aschoff A et al. Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke. Stroke 2002; 33: 1584–8.
- 84 Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346: 549–56.
- 85 Bernard SA, Gray TW, Buist MD et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346: 557–63.
- 86 Hemphill JC III, Bonovich DC, Besmertis L et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32: 891–7.
- 87 Brott T, Broderick J, Kothari R et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1–5.
- 88 Kazui S, Naritomi H, Yamamoto H et al. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1996; 27: 1783–7.
- 89 Mendelow AD, Gregson BA, Fernandes HM et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365: 387–97.
- 90 Morgan T, Zuccarello M, Narayan R et al. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial. Acta Neurochir 2008; 105 (Suppl.): 147–51.
- 91 Teernstra OP, Evers SM, Lodder J et al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 2003; 34: 968–74.
- 92 Mayer SA, Brun NC, Begtrup K et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777–85.
- 93 Flibotte JJ, Hagan N, O'Donnell J et al. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004; 63: 1059–64.
- 94 Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 1992; 23: 972–7.
- 95 Huttner HB, Schellinger PD, Hartmann M et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 2006; 37: 1465–70.
- 96 Schulman S. Clinical practice. Care of patients receiving long-term anticoagulant therapy. N Engl J Med 2003; 349: 675–83.
- 97 Firozvi K, Deveras RA, Kessler CM. Reversal of low-molecular-weight heparin-induced bleeding in patients with pre-existing hypercoagulable states with human recombinant activated factor VII concentrate. Am J Hematol 2006; 81: 582–9.
- 98 Butler AB, Partain RA, Netsky MG. Primary intraventricular hemorrhage. A mild and remediable form. Neurology 1972; 22: 675–87.
- 99 Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 1998; 29: 1352–7.
- 100 Tuhrim S, Horowitz DR, Sacher M et al. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 1999; 27: 617–21.
- 101 Naff NJ, Hanley DF, Keyl PM et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 2004; 54: 577–83; discussion 583–4.
- 102 Lee MW, Pang KY, Ho WW et al. Outcome analysis of intraventricular thrombolytic therapy for intraventricular haemorrhage. Hong Kong Med J 2003; 9: 335–40.
- 103 Nieuwkamp DJ, De Gans K, Rinkel GJ et al. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol 2000; 247: 117–21.
- 104 Huttner HB, Staykov D, Bardutzky J et al. Treatment of intraventricular hemorrhage and hydrocephalus. Nervenarzt 2008; 79: 1369–76.
- 105 Huttner HB, Nagel S, Tognoni E et al. Intracerebral hemorrhage with severe ventricular involvement: lumbar drainage for communicating hydrocephalus. Stroke 2007; 38: 183–7.
- 106 Kassell NF, Torner JC, Jane JA et al. The international cooperative study on the timing of aneurysm surgery. Part 2: surgical results. J Neurosurg 1990; 73: 37–47.
- 107 Handa Y, Kubota T, Tsuchida A et al. Effect of systemic hypotension on cerebral energy metabolism during chronic cerebral vasospasm in primates. J Neurosurg 1993; 78: 112–9.
- 108 Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 2001; 32: 1176–80.
- 109 Van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001; 124: 249–78.
- 110 Siesjo BK. Cellular calcium metabolism, seizures, and ischemia. Mayo Clin Proc 1986; 61: 299–302.
- 111 Dorhout Mees SM, Rinkel GJ, Feigin VL et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007: CD000277.
- 112 Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 2000; 160: 2327–32.
- 113 Molyneux A, Kerr R, Stratton I et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002; 360: 1267–74.
- 114 Brooks NP, Turk AS, Niemann DB et al. Frequency of thromboembolic events associated with endovascular aneurysm treatment: retrospective case series. J Neurosurg 2008; 108: 1095–100.
- 115 Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery 2001; 48: 249–61; discussion 261–2.
- 116 Shimoda M, Oda S, Tsugane R et al. Prognostic factors in delayed ischaemic deficit with vasospasm in patients undergoing early aneurysm surgery. Br J Neurosurg 1997; 11: 210–5.
- 117 Wilkins RH. Cerebral vasospasm. Crit Rev Neurobiol 1990; 6: 51–77.
- 118 Vora YY, Suarez-Almazor M, Steinke DE et al. Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1999; 44: 1237–47; discussion 1247–8.
- 119 Laumer R, Steinmeier R, Gonner F et al. Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 1. Reliability of flow velocities in clinical management. Neurosurgery 1993; 33: 1–8; discussion 8–9.
- 120 Ohtonari T, Kakinuma K, Kito T et al. Diffusion–perfusion mismatch in symptomatic vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 2008; 48: 331–6; discussion 336.
- 121 Hattingen E, Blasel S, Dettmann E et al. Perfusion-weighted MRI to evaluate cerebral autoregulation in aneurysmal subarachnoid haemorrhage. Neuroradiology 2008; 50: 929–38.
- 122 Wood JH, Kee DB Jr Hemorheology of the cerebral circulation in stroke. Stroke 1985; 16: 765–72.
- 123 Naidech AM, Drescher J, Ault ML et al. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 2006; 59: 775–9; discussion 779–80.
- 124 Raabe A, Beck J, Keller M et al. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2005; 103: 974–81.
- 125 Lee KH, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care 2006; 4: 68–76.
- 126 Treggiari MM, Walder B, Suter PM et al. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003; 98: 978–84.
- 127 Shimoda M, Oda S, Tsugane R et al. Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. J Neurosurg 1993; 78: 423–9.
- 128 Buckland MR, Batjer HH, Giesecke AH. Anesthesia for cerebral aneurysm surgery: use of induced hypertension in patients with symptomatic vasospasm. Anesthesiology 1988; 69: 116–9.
- 129 Hasan D, Wijdicks EF, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol 1990; 27: 106–8.
- 130 Segal E, Greenlee JD, Hata SJ et al. Monitoring intravascular volumes to direct hypertensive, hypervolemic therapy in a patient with vasospasm. J Neurosurg Anesthesiol 2004; 16: 296–8.
- 131 Newell DW, Eskridge J, Mayberg M et al. Endovascular treatment of intracranial aneurysms and cerebral vasospasm. Clin Neurosurg 1992; 39: 348–60.
- 132 Eskridge JM, McAuliffe W, Song JK et al. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery 1998; 42: 510–6; discussion 516–7.
- 133 Polin RS, Coenen VA, Hansen CA et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000; 92: 284–90.
- 134 Higashida RT, Halbach VV, Cahan LD et al. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 1989; 71: 648–53.
- 135 Kaku Y, Yonekawa Y, Tsukahara T et al. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992; 77: 842–7.
- 136 Elliott JP, Newell DW, Lam DJ et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998; 88: 277–84.
- 137 Clouston JE, Numaguchi Y, Zoarski GH et al. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. Am J Neuroradiol 1995; 16: 27–38.
- 138 Tsurushima H, Hyodo A, Yoshii Y. Papaverine and vasospasm. J Neurosurg 2000; 92: 509–11.
- 139 Tsurushima H, Kamezaki T, Nagatomo Y et al. Complications associated with intraarterial administration of papaverine for vasospasm following subarachnoid hemorrhage – two case reports. Neurol Med Chir (Tokyo) 2000; 40: 112–5.
- 140 Kassell NF, Helm G, Simmons N et al. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992; 77: 848–52.
